Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome Journal Article

  

Authors:	Jawed, S. I.; Busam, K.; Wang, X.; Horwitz, S.; Querfeld, C.
Article Title:	Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome
Keywords:	immunohistochemistry; adult; human tissue; middle aged; drug tolerability; cancer recurrence; case report; drug dose reduction; drug safety; drug withdrawal; cancer staging; outcome assessment; letter; skin biopsy; dexamethasone; injection site reaction; cancer regression; neutrophil; erythema; histiocyte; lymphocytic infiltration; drug treatment failure; alemtuzumab; clobetasol; medical history; sezary syndrome; human; female; cutaneous hemophagocytosis
Journal Title:	JAMA Dermatology
Volume:	150
Issue:	9
ISSN:	2168-6068
Publisher:	American Medical Association
Date Published:	2014-09-01
Start Page:	1021
End Page:	1023
Language:	English
DOI:	10.1001/jamadermatol.2013.10615
PROVIDER:	scopus
PUBMED:	25029560
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84908233314&partnerID=40&md5=4bb3965982c70a10247fa62b0fc99592
Notes:	Export Date: 1 December 2014 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/65111